Nafarelin

Known as: Nafarelin [Chemical/Ingredient], Nafarelinum, Nafarelina 
A potent synthetic agonist of GONADOTROPIN-RELEASING HORMONE with 3-(2-naphthyl)-D-alanine substitution at residue 6. Nafarelin has been used in the… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
OBJECTIVE To evaluate the efficacy of the GnRH agonist (GnRH-a) nafarelin compared with placebo administered for 6 months after… (More)
Is this relevant?
1995
1995
OBJECTIVES To determine the effectiveness of a 3-month course of nafarelin and, furthermore, to determine the long-term efficacy… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency often have a polycystic ovary-like syndrome… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
BACKGROUND Distinguishing between ovarian and adrenal causes of androgen excess may be difficult. We have found that women with… (More)
Is this relevant?
Review
1992
Review
1992
Quality of life is important when comparing the relative advantages of nafarelin versus danazol for the treatment of… (More)
Is this relevant?
1992
1992
The bioavailability of a single dose of intranasal nafarelin was evaluated in 15 healthy female volunteers. Each subject received… (More)
Is this relevant?
1992
1992
OBJECTIVE To compare the efficacy and safety of nafarelin and danazol for endometriosis. DESIGN Randomized, double-blind… (More)
Is this relevant?
Highly Cited
1989
Highly Cited
1989
To investigate the basis of polycystic ovary syndrome, we examined the responses of patients to nafarelin, a specific… (More)
Is this relevant?
1988
1988
The effect on bone metabolism of an agonist analog of GnRH, nafarelin, was studied in 16 premenopausal women, who received 200… (More)
Is this relevant?
1988
1988
Treatment with nafarelin, a gonadotropin-releasing hormone agonist, reversibly inhibits ovarian function and induces… (More)
Is this relevant?